Thiol compounds inhibit the formation of amyloid fibrils by beta 2-microglobulin at neutral pH

Kaori Yamamoto1, Hisashi Yagi, Daisaku Ozawa

  • 1Institute for Protein Research, Osaka University, and CREST, Japan Science and Technology Agency, Yamadaoka 3-2, Suita, Osaka 565-0871, Japan.

Insights

Reductants like dithiothreitol and cysteine can prevent beta(2)-microglobulin (beta2-m) amyloid fibril formation. This finding offers a potential strategy to inhibit dialysis-related amyloidosis in patients undergoing long-term hemodialysis.

Area of Science:

  • Biochemistry
  • Medical Science
  • Protein Chemistry

Background:

  • Dialysis-related amyloidosis is common in long-term hemodialysis patients.
  • Beta(2)-microglobulin (beta2-m) is the primary component of amyloid fibrils in this condition.
  • Beta(2)-m's disulfide bond stabilizes its native structure and amyloid fibrils.

Purpose of the Study:

  • To investigate the effect of reductants on beta(2)-m amyloid fibril formation.
  • To explore potential preventative strategies for dialysis-related amyloidosis.

Main Methods:

  • Examined the impact of dithiothreitol and cysteine on beta(2)-m fibrillation at neutral pH.
  • Utilized seed-dependent, ultrasonication-induced, and salt-and-heat-induced fibrillation methods.
  • Assessed fibril formation using Thioflavin T fluorescence, electron microscopy, and circular dichroism.

Main Results:

  • Reductants significantly inhibited seed-dependent and ultrasonication-induced beta(2)-m fibrillation.
  • Amyloid fibril formation was markedly reduced in salt-and-heat-induced fibrillation with reductants.
  • A small number of fibrils still formed even after disulfide bond reduction in agitated conditions.

Conclusions:

  • Reductants like cysteine and dithiothreitol show promise in preventing beta(2)-m amyloid fibril formation.
  • These reductants could be beneficial for inhibiting dialysis-related amyloidosis under physiological conditions.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...